MedPath

Carbohydrate antigen19-9 (CA19-9) levels in patients with autosomal dominant polycystic kidney disease (ADPKD)

Not Applicable
Conditions
autosomal dominant polycystic kidney disease
Registration Number
JPRN-UMIN000021735
Lead Sponsor
Iwata City Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

under 18 y.o. and more than 90 y.o.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The serum CA19-9 levels
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath